BlackBerry QNX Expands Beyond Autos with J&J AI Heart Pump
BlackBerry's QNX embedded OS has secured a new deployment in an AI-powered heart pump by Johnson & Johnson, expanding beyond automotive into medical AI and industrial automation. The stock trades at CA$12.86, up 51.3% in 30 days.
Key Numbers
BlackBerry (TSX:BB) has extended its QNX embedded operating system beyond its traditional automotive base into new verticals, with a key deployment in an AI-powered heart pump developed by Johnson & Johnson (NYSE:JNJ).
The Product
QNX, already widely used in automotive infotainment and autonomous driving systems, is now powering a next-generation heart pump from J&J. The platform's real-time reliability and safety certification make it suitable for medical devices where failure is not an option.
Pricing & Availability
Neither company has disclosed pricing or a commercial launch timeline for the heart pump. However, J&J confirmed that QNX serves as the core software platform for the device.
Competition
QNX competes with other real-time operating systems like Wind River's VxWorks and the open-source FreeRTOS. Its long track record in safety-critical applications gives it an edge in medical and industrial markets.
Potential Impact
This deployment diversifies BlackBerry's revenue stream beyond the cyclical automotive sector. It also strengthens QNX's position as a leading platform for embedded safety-critical systems. The stock is currently at CA$12.86, up 51.3% over the past 30 days and 146.4% year-to-date.
Frequently Asked Questions
Found this useful? Share it